Related Experiment Video
Updated: Feb 17, 2026
13:21
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10.6K
Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformatics
Yuandong Feng1, Ying Shen1, Hongli Chen1
1Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Cancer Science
|December 9, 2017
Summary
Long non-coding RNAs (lncRNAs) are implicated in acute myeloid leukemia (AML) progression. Dysregulated lncRNAs impact immune cells and hematopoietic differentiation in AML patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are key regulators in tumorigenesis and cancer progression.
- Their specific roles in acute myeloid leukemia (AML) require further elucidation.
Purpose of the Study:
- To investigate the involvement of lncRNAs in acute myeloid leukemia (AML).
- To identify and functionally annotate lncRNAs dysregulated in AML compared to iron deficiency anemia (IDA).
Main Methods:
- Microarray screening of lncRNA and mRNA expression in AML and IDA patient samples.
- Coexpression analysis to identify lncRNA-mRNA modules.
- Functional annotation and clinical significance analysis of lncRNAs.
- Quantitative RT-PCR validation of key lncRNAs (RP11-222K16.2, AC092580.4, RP11-305O.6).
Main Results:
- Identified dysregulated lncRNAs and mRNAs in AML patients compared to IDA controls.
- Found three lncRNAs (RP11-222K16.2, AC092580.4, RP11-305O.6) with expression levels potentially associated with AML patient survival.
- RP11-222K16.2 may influence natural killer cell differentiation and immune evasion in AML by regulating Eomesodermin.
Conclusions:
- Dysregulated lncRNAs and mRNAs in AML significantly affect the immune system and hematopoietic cell differentiation.
- Specific lncRNAs like RP11-222K16.2 show potential as biomarkers or therapeutic targets in AML.
- Further validation of the biological functions of identified lncRNAs is warranted.
More Related Videos
Related Concept Videos
02:24Ribosome Profiling
4.2K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.2K
02:39lncRNA - Long Non-coding RNAs
3.7K
3.7K
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:34DNA Microarrays
21.3K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.3K